Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer

Journal of Clinical Oncology

Volumn 19, Issue 10, 2001, Pages 2687-2695

  Kemeny, Nancy E ^a   Gonen, M ^a   Sullivan, D ^a   Schwartz, L ^a   Benedetti, F ^a   Saltz, L ^a   Stockman, J ^a   Fong, Y ^a   Jarnagin, W ^a   Bertino, J ^a   Tong, W ^a   Paty, P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLOXURIDINE; IRINOTECAN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CRYOSURGERY; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; MALAISE; MALE; MAXIMUM TOLERATED DOSE; NEUTROPENIA; PEPTIC ULCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0035873927     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.10.2687     Document Type: Article

References (26)

1. Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10:896-903, 1992
2. Saltz LB, Cox JV, Blank C, et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343:905-914, 2000
3. De Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line as first treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947, 2000
4. Fong Y, Cohen AM, Fortner JG, et al: Liver resection for colorectal metastases. J Clin Oncol 15:938-946, 1997
5. Ravikumar TS, Kane R, Cady B, et al: A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg 126:1520-1523, 1991
6. Kemeny N, Cohen A, Bertino JR, et al: Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Cancer 65:2446-2450, 1990
7. Kemeny N, Seiter K, Niedzwieeki D, et al: A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 69:327-334, 1992
8. Kemeny N, Conti JA, Cohen A, et al: Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12:2288-2295, 1994
9. Coombs D, Fine N: Spinal anesthesia using subcutaneously implanted pumps for intrathecal drug infusion. Anesth Analg 73:226-231, 1991
10. Akhurst T, Larson S: Positron emission tomography imaging of colorectal cancer. Semin Oncol 26:577-583, 1999
11. Kaplan EP, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
12. Wilcoxon F: Individual comparisons by ranking methods. Biometrics 1:80-83, 1945
13. Rougier P, Van-Cutbem E, Bujetta E, et al. Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil in patients with metastatic colorectal cancer. Lancet 352:1407-1412, 1998
14. Bierman HR, Byron RL, Kelley KH, et al. Studies on the blood supply of tumor in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. J Natl Cancer Inst 12:107, 1951
15. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252-258, 1996
16. Kemeny N, Atig OT. Nun-surgical treatment fur liver metastases. Baillieres Best Pract Res Clin Gastroenterol 13:593-610, 1999
17. Kemeny N, Huang Y, Cohen AM, et al: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039-2048, 1999
18. Leichman L, Lenz J, Leichman CG, et al: Quantitation of intratumoral thymidylale synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial. Eur J Cancer 31A:1306-1310, 1995
19. Gorlick R, Metzger R, Danenberg KD, et al: Higher levels of hymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J Clin Oncol 16:1465-1469, 1998
20. Saltz L, Danenberg P, Paty P, et al: High thymidylate synthase (TS) expression does not preclude activity of CPT-11 in colorectal cancer (CRC). Proc Am Soc Clin Oncol 17:281a, 1998 (abstr 1080)
21. Rothenberg ML, Eckardt JR, Kuhn JG, et al: Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol 14:1128-1135, 1996
22. Rougier P, Bugat R, Douillard J, et al. Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naïve patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol 15:251-260, 1997
23. Kemeny N, Conti JA, Cohen A, et al: Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12:2288-2295, 1994
24. Morris D, Ross W: Australian experience of cryoablation of liver tumors: Metastases. Surg Oncol Clin North Am 5:391-397, 1996
25. Sasaki Y, Ohtsu A, Shimada Y, et al: Simultaneous administration CPT-11 and fluorouracil: Alteration of the pharmacokinetics of CPT-11 and SN-38 in patients with advanced colorectal cancer. J Natl Cancer Inst 86:1096-1098, 1994 (letter)
26. Saltz LB, Kanowitz J, Kemeny N, et al: Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors. J Clin Oncol 14:2959-2967, 1996